DESOXYN 5 MG
DESOXYN® 5 mg tablets contain methamphetamine hydrochloride, a potent central nervous system (CNS) stimulant of the amphetamine class prescribed for Attention‑Deficit Hyperactivity Disorder (ADHD) in children (≥ 6 years) and adults when clinically appropriate
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
DESOXYN® 5 mg tablets contain methamphetamine hydrochloride, a potent central nervous system (CNS) stimulant of the amphetamine class prescribed for Attention‑Deficit Hyperactivity Disorder (ADHD) in children (≥ 6 years) and adults when clinically appropriate. It may also be used in some indications for obesity under strict clinical guidance.
Active Ingredient:
Methamphetamine Hydrochloride 5 mg (USP) — a sympathomimetic amine with stimulant properties that enhance attention, decrease impulsivity, and reduce hyperactivity in ADHD patients.
Mechanism of Action:
Methamphetamine increases the release of catecholamines (dopamine and norepinephrine) and inhibits their reuptake, resulting in enhanced signaling in areas of the brain associated with focus, alertness, and behavior regulation.
Indications:
ADHD: Approved to improve attention span, reduce distractibility, and manage behavioral symptoms in pediatric and adult patients as part of a comprehensive treatment program.
Obesity (off‑label or specialized programs): In selected cases when alternative therapies have been ineffective.
Dosage & Administration:
Typical starting dose: 5 mg once or twice daily, usually in the morning and early afternoon to reduce insomnia risk.
Titration: Dose may be increased in 5 mg increments weekly based on clinical response; usual effective total is often 20 – 25 mg/day divided into two doses.
Safety & Warnings:
Controlled Substance (CII): Methamphetamine is a Schedule II drug due to high potential for abuse, misuse, dependence, and addiction.
Cardiovascular Risks: Can raise blood pressure and heart rate; monitor patients with heart disease or hypertension.
Psychiatric Effects: May exacerbate anxiety, agitation, aggression, or precipitate psychotic symptoms in some patients.
Peripheral Vasculopathy: Rare but serious circulation issues (e.g., Raynaud’s phenomenon) have been associated with stimulant therapy.
Common Side Effects:
Insomnia, decreased appetite, weight loss
Dry mouth, headache, tremors, rapid heartbeat
Nervousness or irritability
Precautions:
Avoid late‑day dosing to minimize sleep interference.
Assess cardiovascular status before prescribing.
Not recommended for individuals with known stimulant sensitivity or substance abuse history.
Storage:
Store at controlled room temperature (20–25 °C) in a secure location due to its controlled‑drug status.
















Reviews
There are no reviews yet.